Thomas Jetter - DENTSPLY SIRONA Lead Director, Independent Director

XRAY -- USA Stock  

USD 40.07  0.17  0.42%

Mr. Thomas Jetter is Lead Director, Independent Director of the Company. Dr. Jetter serves as Chairman of the Board of Directors of HQ Capital, a privately held alternative asset management firm in Germany. Dr. Jetter is partner and Managing Director of Digital Partners, a Germanbased growth capital management firm focusing on industrytech and fintech software companies since June 2015
Age: 60  Director Since 2016  Ph.D    
Jetter assumed an interim senior leadership position for the Soros Economic Development Fund from January to September 2014 during a restructuring. From April 1995 to March 2008, Dr. Jetter was a Partner at Permira GmbH, where he initiated and managed investments in a variety of industrial, medtech and chemical companies. At Permira, Dr. Jetter gained extensive international experience as lead for investments in the chemicals sector, and helped expand the firm?s global reach to include areas such as the U.S. and China. Prior to that time, Dr. Jetter was a Senior Engagement Manager with McKinsey in Germany and Brazil, where he led projects on cost optimization, organization and strategy. Between 1985 and 1988, Dr. Jetter was an Investment Banking Associate at JP Morgan in Frankfurt and New York.

Management Efficiency

The company has return on total asset (ROA) of 2.64 % which means that it generated profit of $2.64 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.3) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 1.73B in liabilities with Debt to Equity (D/E) ratio of 33.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. DENTSPLY SIRONA has Current Ratio of 1.72 which is within standard range for the sector.

Similar Executives

Showing few of many executives


Anat AshkenaziVarian Medical Systems
TimothyCigna Corporation
Judy BrunerVarian Medical Systems
Chris RobertsResMed
Tadataka YamadaAgilent Technologies
John WarehamResMed
Ken LuChina Cord Blood Corporation
Bala ManianEquillium
Heidi FieldsAgilent Technologies
Howard CoxStryker Corporation
Richard PackerTeleflex Incorporated
Allan GolstonStryker Corporation
James RogersCigna Corporation
Srikant DatarStryker Corporation
Charles McDermottEquillium
Daniel PodolskyAgilent Technologies
Rajeev SuriStryker Corporation
Stephen ConnellyEquillium
Andrew KrakauerTeleflex Incorporated
Gary PaceResMed
Candace DuncanTeleflex Incorporated

Entity Summary

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania. DENTSPLY SIRONA operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ. It employs 16100 people.DENTSPLY SIRONA (XRAY) is traded on NASDAQ in USA and employs 16,100 people.


Maureen MacInnis, Chief Human Resource Officer, Senior Vice President
Thomas Jetter, Lead Director, Independent Director
Ulrich Michel, CFO, Executive Vice President
Rainer Berthan, Executive Vice President Manufacturing and Supply Chain
Paula Cholmondeley, Independent Director
John Sweeney, vice president IR Contact Officer
Francis Lunger, Independent Director
Robert Size, Sr. VP
Christopher Clark, Pres and CFO
Harry Kraemer, Director
Deborah Rasin, Vice President General Counsel, Secretary
Michael Coleman, Independent Director
Betsy Holden, Director
David Beecken, Director
Leslie Varon, Director
Eric Brandt, Independent Director
Donald Casey, CEO, Director
Derek Leckow, VP, Investor Relations
Willie Deese, Independent Director
Nicholas Alexos, Executive Vice President Chief Administrative Officer
Justin McCarthy, General Counsel, Secretary
Albert Sterkenburg, Senior Vice President
Keith Ebling, Executive Vice President General Counsel, Secretary
John Miles, Independent Director
William Hecht, Lead Independent Director
Michael Alfano, Independent Director
James Mosch, COO and Executive VP
Jonathan Friedman, Senior Vice President General Counsel, Secretary
Mark Thierer, Interim CEO
John Miclot, Independent Director
Bret Wise, Chairman, CEO and Chairman of Executive Committee
Arthur Kowaloff, Director
Jeffrey Slovin, CEO, Director

Stock Performance Indicators

Did you try this?

Run Risk-Return Analysis Now


Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Risk-Return Analysis

Also Currentnly Active

Purchased over 300 shares of
2 days ago
Traded for 8.99
Purchased over 20 shares of
2 days ago
Traded for 145.23
Purchased over 20 shares of
2 days ago
Traded for 102.17
See also Your Current Watchlist. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.